FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/16/2022
Back to search
Official data from USPTO
NOVOTECH HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NOVOTECH HEALTH
ST13
US500000079311087Class
42
Filing
79311087
Registration
6641668
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/16/2022
Trademark type
Word
Nice classes
42
Filing date
10/26/2020
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
02/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
COLTON, BRITTANY
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novotech (Australia) Pty Ltd
Representatives
Matthew P. Hintz, Esq. Lowenstein Sandler LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
conducting clinical trials for others; conducting and managing clinical trials for others in the field of pharmaceuticalsbiotechnology and other related industries; conducting clinical trials for others scientific research; providing medical and scientific research information about the results of clinical trials in the nature of clinical trials for pharmaceuticals and biotechnology; scientific research; medical research; preparation of statisticsscientific analysis in the field of clinical trial results for scientific research; preparation of biostatisticsscientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticalsbiotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticalsbiotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research servicesmedical monitoring services for research in the fields of pharmaceuticalsbiotechnology and other related industries; quality auditsquality evaluation of site compliance with clinical trial protocols and standards; preparation of reports and applications to regulators relating to aspects of clinical trialsproviding medical and scientific information and data in the field of conducting clinical trials; provision of medical and scientific research information and data between scientistsmanufacturers and health authorities relating to pharmaceutical and biotechnology quality standardspreparation of reports and applications on the quality and standard of clinical trials; technical writing of clinical report forms which are required by clinical trial drug protocols
Publications
History of USPTO decisions and trademark events.
28 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/22/2022
FIMP
FINAL DISPOSITION PROCESSED
07/22/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/15/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2022
GPNX
NOTIFICATION PROCESSED BY IB
12/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/30/2021
PUBO
PUBLISHED FOR OPPOSITION
11/30/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/28/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/28/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/28/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/28/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2021
RFNT
REFUSAL PROCESSED BY IB
06/28/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/10/2021
RFRR
REFUSAL PROCESSED BY MPU
06/10/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/09/2021
CNRT
NON-FINAL ACTION WRITTEN
06/08/2021
MAFR
APPLICATION FILING RECEIPT MAILED
05/25/2021
DOCK
ASSIGNED TO EXAMINER
05/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/21/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/20/2021
Continuous trademark protection
Get notified about every new filing that threatens NOVOTECH HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.